September 2025: Neighborhood Social Vulnerabi...

Dr. Suresh Durgam (Intra-Cellular Therapies, a Johnson & Johnson Company, Bedminster, NJ) joins AJP Audio to discuss a phase 3 randomized controlled trial looking at the use of the antipsychotic medication lumateperone as adjunctive to antidepressant therapy in the treatment of p ...  Show more

Dr. Lara Coughlin (University of Michigan, Ann Arbor) joins AJP Audio to discuss a study looking the impact of contingency management on all cause mortality in patients with stimulant use disorder. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin discusses the rest of the November i ...  Show more

In the fourth edition of the Inside JABA Series, I am joined by Drs. Dorothea Lerman, Linda LeBlanc, and Matt Normand to discuss the forthcoming JABA Special Series on Telehealth and Public Health.

Dr. Mariel Buqué joins the podcast to help us learn how we can heal from the past, create healthier patterns, and break cycles of trauma. Forrest and Dr. Buqué talk about what intergenerational trauma is, how we can “hand trauma down,” and how these problematic patterns show up i ...  Show more

Jenseits der Evidenz: Wie individuelle Erfahrungen von Menschen in Heilberufen die moderne Medizin bereichern. 

Welcome back to Therapy Chat! In today's podcast host Laura Reagan revisits an earlier episode speaking to Dr. Gabor Maté. Dr. Maté is the co-founder of Compassion for Addiction, a new non-profit that focuses on addiction. He is also an advisor of Drugs over Dinner. As an author, ...  Show more